scholarly journals XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis

2015 ◽  
Vol 9 (5) ◽  
pp. 2425-2429 ◽  
Author(s):  
JINGHUA FAN ◽  
YUHUA FAN ◽  
XIAOXIAO KANG ◽  
LIMIN ZHAO
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Skin Cancer Risk ◽  
Melanoma Skin

Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: A comprehensive review and meta-analysis

2014 ◽  
Vol 50 (15) ◽  
pp. 2649-2658 ◽  
Author(s):  
Saverio Caini ◽  
Mathieu Boniol ◽  
Giulio Tosti ◽  
Serena Magi ◽  
Matelda Medri ◽  
...  
Keyword(s):  
Vitamin D ◽  
Skin Cancer ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Comprehensive Review ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

scholarly journals Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study

2019 ◽  
Vol 121 (11) ◽  
pp. 973-978 ◽  
Author(s):  
Anton Pottegård ◽  
Sidsel Arnspang Pedersen ◽  
Sigrun Alba Johannesdottir Schmidt ◽  
Chaw-Ning Lee ◽  
Chao-Kai Hsu ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Asian Population ◽  
Case Control ◽  
Sensitivity Analyses ◽  
Research Database ◽  
Lip Cancer ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Abstract Background The antihypertensive agent hydrochlorothiazide has been associated with increased risks of non-melanoma skin cancer (NMSC) and possibly some melanoma subtypes. Previous studies were, however, conducted in predominantly Caucasian populations. We therefore examined the association between hydrochlorothiazide and skin cancer risk in an Asian population. Methods By using Taiwan’s National Health Insurance Research Database (NHIRD), we conducted three separate case–control studies of lip cancer, non-lip non-melanoma skin cancer and melanoma. Cases (n = 29,082) with a first-ever skin cancer diagnoses (2008–2015) were matched 1:10 to population controls. We estimated odds ratios (ORs) associating hydrochlorothiazide use with skin cancer risk by using conditional logistic regression. Results Hydrochlorothiazide use showed no overall association with any of the three outcomes: ORs for high cumulative use of HCTZ (≥50,000 mg) were 0.86 (95% CI 0.09–7.81) for lip cancer, 1.16 (95% CI 0.98–1.37) for non-lip NMSC and 1.07 (95% CI 0.65–1.76) for melanoma. There was some evidence of a dose–response pattern for non-lip NMSC, with an OR of 1.66 (95% CI 0.82–3.33) for 100,000–149,999 mg of HCTZ. The null findings were robust across subgroup and sensitivity analyses. Conclusion Use of HCTZ appears safe in terms of skin cancer risk in an Asian population.

Non-melanoma skin cancer risk in the Queensland renal transplant population

2002 ◽  
Vol 147 (5) ◽  
pp. 950-956 ◽  
Author(s):  
H.M. Ramsay ◽  
A.A. Fryer ◽  
C.M. Hawley ◽  
A.G. Smith ◽  
D.L. Nicol ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Renal Transplant ◽  
Cancer Risk ◽  
Skin Cancer Risk ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

scholarly journals Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies

Oncotarget ◽  
2017 ◽  
Vol 8 (43) ◽  
pp. 75411-75417 ◽  
Author(s):  
Keming Yang ◽  
Andrew Marley ◽  
Huilin Tang ◽  
Yiqing Song ◽  
Jean Y. Tang ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Randomized Controlled Trials ◽  
Observational Studies ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Randomized Controlled ◽  
Non Melanoma Skin Cancer ◽  
Statin Use ◽  
Melanoma Skin

Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis

2018 ◽  
Vol 122 ◽  
pp. 1-9 ◽  
Author(s):  
Sara Gandini ◽  
Domenico Palli ◽  
Giuseppe Spadola ◽  
Benedetta Bendinelli ◽  
Emilia Cocorocchio ◽  
...  
Keyword(s):  
Skin Cancer ◽  
Cancer Risk ◽  
Meta Analysis ◽  
Review Of The Literature ◽  
Skin Cancer Risk
Sign in / Sign up

Export Citation Format

Share Document